AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2014
May 13, 2014
35134_dirs_2014-05-13_828e042e-86aa-40b6-9e5f-5f1bd5e8801a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-05-09
Reporting Person: LaPenta Robert V Jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-09 | Common Stock | P | 2000 | $3.58 | Acquired | 7000 | Direct |
| 2014-05-09 | Common Stock | P | 3000 | $3.72 | Acquired | 10000 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16